Our lab is evolving techniques to extract quantifiable information from contrast-enhanced ultrasound (CEUS). As CEUS evaluates tissue perfusion, we believe this may provide a surrogate noninvasive marker for angiogenesis and assessment of antiangiogenic treatment.
Funding: CTSI, RSNA, Wright foundation, Stern Foundation, USC Dean’s Medical Student Grant, Samsung Healthcare, GE,
| Selected published Papers | PMID 31499247, 31237009, 30284307, 30117172, 26206837, 26036794 |
| Abstracts | Multiple abstracts at ARRS, SAR, AUA, RSNA, and SPIE annual meetings |
Ongoing work:
a) Utility of ultrasound texture in decision making
b) Assessment of angiogenesis in chemotherapy
